留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝移植围手术期门静脉血栓管理的研究进展

吕少诚, 贺强. 肝移植围手术期门静脉血栓管理的研究进展[J]. 器官移植, 2024, 15(1): 26-32. doi: 10.3969/j.issn.1674-7445.2023185
引用本文: 吕少诚, 贺强. 肝移植围手术期门静脉血栓管理的研究进展[J]. 器官移植, 2024, 15(1): 26-32. doi: 10.3969/j.issn.1674-7445.2023185
Lyu Shaocheng, He Qiang. Research progress in perioperative management of portal vein thrombosis in liver transplantation[J]. ORGAN TRANSPLANTATION, 2024, 15(1): 26-32. doi: 10.3969/j.issn.1674-7445.2023185
Citation: Lyu Shaocheng, He Qiang. Research progress in perioperative management of portal vein thrombosis in liver transplantation[J]. ORGAN TRANSPLANTATION, 2024, 15(1): 26-32. doi: 10.3969/j.issn.1674-7445.2023185

肝移植围手术期门静脉血栓管理的研究进展

doi: 10.3969/j.issn.1674-7445.2023185
基金项目: 北京市自然科学基金面上项目(7212042);首都临床诊疗技术研究及示范应用项目(Z211100002921025);首都医科大学附属北京朝阳医院临床研究孵化项目(CYFH202214)
详细信息
    作者简介:
    通讯作者:

    贺强(ORCID 0000-0002-5007-5225),博士,主任医师,研究方向为肝移植与胰腺癌的临床与基础研究,Email: heqiang349@163.com

  • 中图分类号: R617, R364.1+5

Research progress in perioperative management of portal vein thrombosis in liver transplantation

More Information
    Author Bio:

    吕少诚,现任首都医科大学附属北京朝阳医院肝胆外科副主任医师,讲师,研究方向为肝移植围手术期管理及术后免疫调控的相关机制。兼任中华医学会肠外肠内营养学分会加速康复外科协助组组员、中国医疗保健国际交流促进会胰腺病学分会委员、北京医师协会门静脉高压症多学科诊治医师分会委员、中国医疗保健国际交流促进会肝脏移植学分会工作秘书。兼任《器官移植》《国际外科学杂志》通讯编委,《中华肝脏外科手术学电子杂志》青年编委。主持北京市自然科学基金1项,参与国家级及省部级课题3项。获教育部科技进步二等奖一项。发表论文40余篇,其中中文核心期刊论文10余篇,SCI论文20余篇

    Corresponding author: He Qiang, Email: heqiang349@163.com
  • 摘要: 门静脉血栓是肝硬化的常见并发症之一,其发生率随着疾病的发展而增加。门静脉血栓的发生发展与多种因素有关,抗凝治疗的指征仍需进一步研究探索。门静脉血栓目前已不再认为是肝移植手术的禁忌,但是复杂的门静脉血栓会增加肝移植围手术期风险,如何恢复门静脉系统血流是临床手术方案决策的难点,合理的术前分型、手术规划和门静脉重建方式是保障肝移植受者远期良好预后的关键。本文就门静脉血栓的流行病学现状、危险因素、分型与鉴别,肝移植术前门静脉血栓管理和术中处理,以及门静脉血栓对肝移植结局的影响进行综述,为肝移植围手术期门静脉血栓的管理提供参考。

     

  • [1] KWONG AJ, EBEL NH, KIM WR, et al. OPTN/SRTR 2021 annual data report: liver[J]. Am J Transplant, 2023, 23(2 Suppl 1): S178-S263. DOI: 10.1016/j.ajt.2023.02.006.
    [2] XIAO J, WANG F, WONG NK, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective[J]. J Hepatol, 2019, 71(1): 212-221. DOI: 10.1016/j.jhep.2019.03.004.
    [3] WEI B, HUANG Z, TANG C. Optimal treatment for patients with cavernous transformation of the portal vein[J]. Front Med (Lausanne), 2022, 9: 853138. DOI: 10.3389/fmed.2022.853138.
    [4] PAN J, WANG L, GAO F, et al. Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis[J]. Eur J Intern Med, 2022, 104: 21-32. DOI: 10.1016/j.ejim.2022.05.032.
    [5] GIRI S, SINGH A, KOLHE K, et al. Natural history of portal vein thrombosis in cirrhosis: a systematic review with meta-analysis[J]. J Gastroenterol Hepatol, 2023, 38(10): 1710-1717. DOI: 10.1111/jgh.16263.
    [6] ORLANDO G, DE LUCA L, TOTI L, et al. Liver transplantation in the presence of portal vein thrombosis: report from a single center[J]. Transplant Proc, 2004, 36(1): 199-202. DOI: 10.1016/j.transproceed.2003.11.014.
    [7] MARUYAMA H, OKUGAWA H, TAKAHASHI M, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes[J]. Am J Gastroenterol, 2013, 108(4): 568-574. DOI: 10.1038/ajg.2012.452.
    [8] 吴治念, 肖滢, 王亚东. 肝硬化门静脉血栓形成机制和治疗新认识[J]. 中华肝脏病杂志, 2022, 30(11): 1280-1284. DOI: 10.3760/cma.j.cn501113-20220322-00131.

    WU ZN, XIAO Y, WANG YD. New recognition of portal vein thrombosis mechanism and treatment in cirrhosis[J]. Chin J Hepatol, 2022, 30(11): 1280-1284. DOI: 10.3760/cma.j.cn501113-20220322-00131.
    [9] 张颖. 乙肝肝硬化患者门静脉血栓形成的影响因素分析[J]. 临床医学, 2023, 43(2): 37-39. DOI: 10.19528/j.issn.1003-3548.2023.02.012.

    ZHANG Y. Analysis of influencing factors of portal vein thrombosis in patients with hepatitis B cirrhosis[J]. Clin Med, 2023, 43(2): 37-39. DOI: 10.19528/j.issn.1003-3548.2023.02.012.
    [10] SHUKLA A, GIRI S. Portal vein thrombosis in cirrhosis[J]. J Clin Exp Hepatol, 2022, 12(3): 965-979. DOI: 10.1016/j.jceh.2021.11.003.
    [11] ANTON A, CAMPRECIÓS G, PÉREZ-CAMPUZANO V, et al. The pathophysiology of portal vein thrombosis in cirrhosis: getting deeper into Virchow's triad[J]. J Clin Med, 2022, 11(3): 800. DOI: 10.3390/jcm11030800.
    [12] STIEBER AC, ZETTI G, TODO S, et al. The spectrum of portal vein thrombosis in liver transplantation[J]. Ann Surg, 1991, 213(3): 199-206. DOI: 10.1097/00000658-199103000-00003.
    [13] YERDEL MA, GUNSON B, MIRZA D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome[J]. Transplantation, 2000, 69(9): 1873-1881. DOI: 10.1097/00007890-200005150-00023.
    [14] JAMIESON NV. Changing perspectives in portal vein thrombosis and liver transplantation[J]. Transplantation, 2000, 69(9): 1772-1774. DOI: 10.1097/00007890-200005150-00006.
    [15] CHARCO R, FUSTER J, FONDEVILA C, et al. Portal vein thrombosis in liver transplantation[J]. Transplant Proc, 2005, 37(9): 3904-3905. DOI: 10.1016/j.transproceed.2005.09.120.
    [16] SARIN SK, PHILIPS CA, KAMATH PS, et al. Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis[J]. Gastroenterology, 2016, 151(4): 574-577. DOI: 10.1053/j.gastro.2016.08.033.
    [17] 王乐, 郭晓钟, 祁兴顺. 肝硬化门静脉血栓的临床评估与治疗: 当前观点[J]. 解放军医学杂志, 2023, 48(1): 18-26. DOI: 10.11855/j.issn.0577-7402.2023.01.0018.

    WANG L, GUO XZ, QI XS. Clinical assessment and treatment of portal vein thrombosis in liver cirrhosis: current perspectives[J]. Med J Chin PLA, 2023, 48(1): 18-26. DOI: 10.11855/j.issn.0577-7402.2023.01.0018.
    [18] NORTHUP PG, GARCIA-PAGAN JC, GARCIA-TSAO G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2021, 73(1): 366-413. DOI: 10.1002/hep.31646.
    [19] European Association for the Study of the Liver. EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis[J]. J Hepatol, 2022, 76(5): 1151-1184. DOI: 10.1016/j.jhep.2021.09.003.
    [20] YOSHIJI H, NAGOSHI S, AKAHANE T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020[J]. Hepatol Res, 2021, 51(7): 725-749. DOI: 10.1111/hepr.13678.
    [21] 中华医学会消化病学分会肝胆疾病学组. 肝硬化门静脉血栓管理专家共识(2020年, 上海)[J]. 临床肝胆病杂志, 2020, 36(12): 2667-2674. DOI: 10.3969/j.issn.1001-5256.2020.12.007.

    Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai) [J]. J Clin Hepatol, 2020, 28(12): 999-1007. DOI: 10.3760/cma.j.cn501113-20201112-00612.
    [22] DE FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno VII - renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
    [23] 徐晓桐, 刘宇维, 金晶兰. 肝硬化伴门静脉血栓患者中使用新型口服抗凝药效果评价的荟萃分析[J]. 中华肝脏病杂志, 2023, 31(6): 614-620. DOI: 10.3760/cma.j.cn501113-20230310-00103.

    XU XT, LIU YW, JIN JL. Efficacy evaluation of novel oral anticoagulants in patients with cirrhosis accompanied with portal vein thrombosis: a meta-analysis[J]. Chin J Hepatol, 2023, 31(6): 614-620. DOI: 10.3760/cma.j.cn501113-20230310-00103.
    [24] LOFFREDO L, PASTORI D, FARCOMENI A, et al. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis[J]. Gastroenterology, 2017, 153(2): 480-487. DOI: 10.1053/j.gastro.2017.04.042.
    [25] 杨莹, 石彭宇, 张曼曼. 肝硬化门静脉高压合并门静脉血栓行TIPS治疗临床分析[J]. 中国现代普通外科进展, 2023, 26(3): 218-221. DOI: 10.3969/j.issn.1009-9905.2023.03.012.

    YANG Y, SHI PY, ZHANG MM. Clinical analysis of TIPS treatment for cirrhotic portal hypertension combined with portal vein thrombosis[J]. Chin J Curr Adv Gen Surg, 2023, 26(3): 218-221. DOI: 10.3969/j.issn.1009-9905.2023.03.012.
    [26] ALANI M, ROWLEY M, KANG P, et al. Utility of transjugular intrahepatic portosystemic shunt placement for maintaining portal vein patency in candidates on wait lists who develop thrombus[J]. Exp Clin Transplant, 2020, 18(7): 808-813. DOI: 10.6002/ect.2019.0153.
    [27] DE SANTIS A, MOSCATELLI R, CATALANO C, et al. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study[J]. Dig Liver Dis, 2010, 42(6): 451-455. DOI: 10.1016/j.dld.2009.08.009.
    [28] 张杰, 李文华. 肝硬化门静脉血栓的管理新进展[J]. 临床医药实践, 2023, 32(7): 522-526.

    ZHANG J, LI WH. New progress in the management of portal vein thrombosis in liver cirrhosis[J]. Proc Clin Med, 2023, 32(7): 522-526.
    [29] AK C, ADALI G, SAYAR S, et al. Portal vein thrombosis risk factors in liver transplant candidates[J]. Hepatol Forum, 2022, 3(3): 88-92. DOI: 10.14744/hf.2022.2022.0005.
    [30] VILLA E, CAMMÀ C, MARIETTA M, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis[J]. Gastroenterology, 2012, 143(5): 1253-1260. DOI: 10.1053/j.gastro.2012.07.018.
    [31] YANG M, LIU J. Low-molecular weight heparin prevents portal vein system thrombosis after splenectomy: a systematic review and meta-analysis[J]. ANZ J Surg, 2020, 90(12): 2420-2424. DOI: 10.1111/ans.15865.
    [32] LIAO Z, WANG Z, SU C, et al. Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: a systematic review and meta-analysis[J]. PLoS One, 2023, 18(8): e0290164. DOI: 10.1371/journal.pone.0290164.
    [33] PAN C, SHI Y, ZHANG JJ, et al. Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China[J]. Transplant Proc, 2009, 41(9): 3761-3765. DOI: 10.1016/j.transproceed.2009.06.215.
    [34] KASAHARA M, SASAKI K, UCHIDA H, et al. Novel technique for pediatric living donor liver transplantation in patients with portal vein obstruction: the "pullout technique"[J]. Pediatr Transplant, 2018, 22(8): e13297. DOI: 10.1111/petr.13297.
    [35] ZHAO D, HUANG YM, LIANG ZM, et al. Reconstructing the portal vein through a posterior pancreatic tunnel: new choice for portal vein thrombosis during liver transplantation[J]. World J Gastrointest Surg, 2022, 14(10): 1131-1140. DOI: 10.4240/wjgs.v14.i10.1131.
    [36] VIANNA RM, MANGUS RS, KUBAL C, et al. Multivisceral transplantation for diffuse portomesenteric thrombosis[J]. Ann Surg, 2012, 255(6): 1144-1150. DOI: 10.1097/SLA.0b013e31825429c0.
    [37] D'AMICO G, HASSAN A, DIAGO USO T, et al. Renoportal anastomosis in liver transplantation and its impact on patient outcomes: a systematic literature review[J]. Transpl Int, 2019, 32(2): 117-127. DOI: 10.1111/tri.13368.
    [38] SELVAGGI G, WEPPLER D, NISHIDA S, et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis[J]. Am J Transplant, 2007, 7(2): 454-460. DOI: 10.1111/j.1600-6143.2006.01649.x.
    [39] TENG F, SUN KY, FU ZR. Tailored classification of portal vein thrombosis for liver transplantation: focus on strategies for portal vein inflow reconstruction[J]. World J Gastroenterol, 2020, 26(21): 2691-2701. DOI: 10.3748/wjg.v26.i21.2691.
    [40] DURÁN M, ALFARAH J, HANN A, et al. Reconstruction for complex portal vein thrombosis - anatomical if possible[J]. J Hepatol, 2023, 79(3): e129-e131. DOI: 10.1016/j.jhep.2023.03.019.
    [41] DE SANTIBANES M, ARDILES V, UÑO JW, et al. Surgical strategies to treat portal vein thrombosis during adult liver transplantation[J]. Langenbecks Arch Surg, 2023, 408(1): 399. DOI: 10.1007/s00423-023-03141-7.
    [42] LLADÓ L, FABREGAT J, CASTELLOTE J, et al. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality[J]. Clin Transplant, 2007, 21(6): 716-721. DOI: 10.1111/j.1399-0012.2007.00728.x.
    [43] SHARSHAR M, YAGI S, IIDA T, et al. Liver transplantation in patients with portal vein thrombosis: a strategic road map throughout management[J]. Surgery, 2020, 168(6): 1160-1168. DOI: 10.1016/j.surg.2020.07.023.
    [44] BHANGUI P, LIM C, LEVESQUE E, et al. Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation[J]. J Hepatol, 2019, 71(5): 1038-1050. DOI: 10.1016/j.jhep.2019.08.012.
    [45] YANG Z, WANG S, LERUT J, et al. Portal inflow reconstruction for liver transplantation with portal vein thrombosis[J]. Hepatobiliary Surg Nutr, 2021, 10(2): 291-294. DOI: 10.21037/hbsn-20-797.
    [46] 滕飞, 傅志仁. 肝移植中基于门静脉重建方案的门静脉血栓分类及处理策略[J]. 器官移植, 2018, 9(4): 245-249. DOI: 10.3969/j.issn.1674-7445.2018.04.001.

    TENG F, FU ZR. Classification and management strategy of portal vein thrombosis based on portal vein reconstruction scheme in liver transplantation[J]. Organ Transplant, 2018, 9(4): 245-249. DOI: 10.3969/j.issn.1674-7445.2018.04.001.
    [47] FUNDORA Y, HESSHEIMER AJ, DEL PRETE L, et al. Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis[J]. J Hepatol, 2023, 78(4): 794-804. DOI: 10.1016/j.jhep.2023.01.007.
    [48] PINELLI D, CESCON M, RAVAIOLI M, et al. Liver transplantation in patients with portal vein thrombosis: revisiting outcomes according to surgical techniques[J]. J Clin Med, 2023, 12(7): 2457. DOI: 10.3390/jcm12072457.
    [49] GHABRIL M, AGARWAL S, LACERDA M, et al. Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients[J]. Transplantation, 2016, 100(1): 126-133. DOI: 10.1097/TP.0000000000000785.
    [50] NACIF LS, ZANINI LY, PINHEIRO RS, et al. Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: systematic review and meta-analysis[J]. Clinics (Sao Paulo), 2021, 76: e2184. DOI: 10.6061/clinics/2021/e2184.
  • 加载中
图(1)
计量
  • 文章访问数:  152
  • HTML全文浏览量:  99
  • PDF下载量:  28
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-09-20
  • 网络出版日期:  2023-11-29
  • 刊出日期:  2024-01-11

目录

    /

    返回文章
    返回